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Research
A substantial body of literature has shown asso­
ciations of particulate air pollution with mor­
tality and specifically cardiovascular disease. 
Recent studies have focused on the fine frac­
tion < 2.5 µm in diameter (PM2.5) (Eftim et al. 
2008; Laden et al. 2006; Miller et al. 2007). 
However, some studies have suggested that 
the coarse fraction, particles between 10 and 
2.5 µm (PM10‒2.5), may be important as well 
(Brunekreef and Forsberg 2005; Host et al. 
2008; Lipsett et al. 2006). A recent study in the 
Women’s Health Initiative (WHI) reported 
a 24% increase in the risk of a cardio  vascular 
event [hazard ratio (HR) = 1.24; 95% con­
fidence interval (CI), 1.09‒1.41] and a 76% 
increase in the risk of death from cardio  vascular 
disease (HR = 1.76; 95% CI, 1.25‒2.47) for 
each 10­µg/m3 change in PM2.5 levels meas­
ured in 2000 (Miller et al. 2007). The mag­
nitude of these estimates is higher than those 
reported in most long­term follow­up studies 
(Laden et al. 2006; Pope et al. 2002). Neither 
Pope et al. (2002) nor Miller and coauthors 
(2007) observed evidence of a positive associa­
tion with PM10‒2.5 . 
We previously observed a positive asso­
ciation of chronic PM10 (particles < 10 µm 
in aerodynamic diameter) exposures and all­
cause mortality and fatal coronary heart disease 
(CHD) in the Nurses’ Health Study (NHS), a 
prospective cohort study of U.S. women (Puett 
et al. 2008). In the current study, we extend 
that study to look specific  ally at exposures to 
PM2.5 and PM10‒2.5 in the same population. 
This longstanding cohort provides a unique 
opportunity with biennial updated assessment 
of covariates to examine these associations. 
With the geocoding of the nurses’ biennially 
updated residential addresses and the recent 
development of geographic information sys­
tems (GIS)–based spatial smoothing models, 
this study uses time­ and space­resolved PM2.5 
and PM10‒2.5 exposures at the monthly level. 
This individual­specific exposure assessment 
approach has not been possible in many previ­
ous studies of chronic air pollutant effects. 
Methods
Study population. The NHS began in 1976 
with 121,700 female registered nurses who 
lived in 11 states (California, Texas, Florida, 
Massachusetts, Pennsylvania, Ohio, New 
York, New Jersey, Michigan, Connecticut, 
and Maryland), were born between 1921 and 
1946, completed a baseline questionnaire, and 
provided informed consent. The Brigham and 
Women’s Hospital Institutional Review Board 
approved all aspects of this study. Participants 
have been mailed biennial questionnaires to 
their residential address to obtain information 
on risk factors and health outcomes since the 
study’s inception. Among nurses available for 
follow­up, about 6% did not respond to cur­
rent questionnaires. For the current study we 
included participants who were living from 
1992 until 2002 in metropolitan statistical areas 
(MSAs) of 13 contiguous states in the northeast 
and midwest United States (Maine, Vermont, 
New Hampshire, Ohio, Pennsylvania, 
Maryland,  Michigan,  Massachusetts, 
Connecticut, Rhode Island, New York, New 
Jersey, Delaware). We chose to limit the study 
population to women residing in MSAs (about 
87% of participants in this geographic region) 
to allow for comparisons with results from pre­
vious studies that also have focused on met­
ropolitan areas (Eftim et al. 2008; Pope et al. 
1995, 2002) and because the distributions of 
air pollution monitors and nurses were more 
sparse outside MSAs. Women were excluded 
for any time period of follow­up during which 
they resided outside this geographic region. 
Nonfatal myocardial infarctions (MIs) 
were assessed through biennial questionnaires 
and confirmed through medical record review 
by physicians blinded to study parti  cipants’ 
exposure status. Deaths were obtained through 
next of kin, postal authority reports, death cer­
tificates, or the National Death Index. Fatal 
CHD was confirmed by death certificate, hos­
pital records, or autopsy. Additional details 
regarding the assessment and confirmation 
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Ba c k g r o u n d: The relationship of fine particulate matter < 2.5 µm in diameter (PM2.5) air 
  pollution with mortality and cardiovascular disease is well established, with more recent long-term 
studies reporting larger effect sizes than earlier long-term studies. Some studies have suggested the 
coarse fraction, particles between 2.5 and 10 µm (PM10‒2.5), may also be important. With respect to 
mortality and cardiovascular events, questions remain regarding the relative strength of effect sizes 
for chronic exposure to fine and coarse particles.
oBjectives: We examined the relationship of chronic PM2.5 and PM10‒2.5 exposures with all-cause mor-
tality and fatal and nonfatal incident coronary heart disease (CHD), adjusting for time-varying covariates. 
Me t h o d s : The current study included women from the Nurses’ Health Study living in metropolitan 
areas of the northeastern and midwestern United States. Follow-up was from 1992 to 2002. We used 
geographic information systems–based spatial smoothing models to estimate monthly exposures at 
each participant’s residence.
re s u l t s: We found increased risk of all-cause mortality [hazard ratio (HR), 1.26; 95% confidence inter-
val (CI), 1.02‒1.54] and fatal CHD (HR = 2.02; 95% CI, 1.07‒3.78) associated with each 10-µg/m3 
increase in annual PM2.5 exposure. The association between fatal CHD and PM10‒2.5 was weaker.
co n c l u s i o n s: Our findings contribute to growing evidence that chronic PM2.5 exposure is associated 
with risk of all-cause and cardiovascular mortality. 
key w o r d s : air pollution, cardiovascular disease, mortality, particulate matter. Environ Health 
Perspect 117:1697–1701 (2009).  doi:10.1289/ehp.0900572 available via http://dx.doi.org/ [Online 
15 June 2009]Puett et al.
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of nonfatal MI, first­incident nonfatal or fatal 
CHD, fatal CHD, and all­cause mortality for 
the current study are described elsewhere (Puett 
et al. 2008). Only cases indicated as definitely 
or probably confirmed were counted. Women 
reporting cancers prior to 1992 (other than 
nonmelanoma skin cancer) were excluded at 
the beginning of follow­up. Accidental deaths 
were excluded from the all­cause mortality 
analysis. Women with nonfatal MIs prior to 
baseline were excluded from fatal and nonfatal 
incident CHD cases for the current study.
Exposure assessment. Separate spatio­
temporal models for PM10 and PM2.5 were 
developed and validated, with coarse particle 
levels estimated by subtraction of predicted 
PM2.5 from predicted PM10 (Paciorek et al. 
2009; Yanosky et al. 2008, 2009).
The PM10 model is a GIS­based spatial 
smoothing model that predicts monthly outdoor 
concentrations specific to each participant’s bien­
nially updated residence. This generalized addi­
tive mixed model [GAMM, detailed elsewhere 
(Paciorek et al. 2009; Yanosky et al. 2008)] 
used monitoring data from sites in the U.S. 
Environmental Protection Agency’s Air Quality 
System (U.S. EPA 2007), the Interagency 
Monitoring of Protected Visual Environments 
(IMPROVE) network (National Aeronautics 
and Space Administration 2009), Clean Air 
Status and Trends Network (CASTNet, U.S. 
EPA 2009) data, and Harvard research stud­
ies to estimate monthly smooth spatial terms 
and penalized regression terms of GIS­based 
and meteorologic covariates. These covariates 
included population density; distance to near­
est road by Census Feature Class Code A1­3; 
elevation; urban land use; point­ and area­source 
PM10 emissions; wind speed; and precipitation. 
We followed a similar process to pre­
dict monthly outdoor PM2.5 concentrations 
(Paciorek et al. 2009; Yanosky et al. 2009). 
Briefly, because of the lack of PM2.5 moni­
tor data before 1999, we constructed separate 
models for 1988‒1998 and 1999‒2002. The 
post­1999 PM2.5 model was of similar form to 
the PM10 model, and with similar covariates 
but used point­source PM2.5 emissions. The 
pre­1999 model used a simpler spatiotemporal 
structure to estimate the PM2.5 to PM10 ratio 
seasonally and used estimated extinction coef­
ficients and covariates described previously. We 
estimated PM10‒2.5 exposures by subtracting 
the modeled PM2.5 estimates from the PM10 
modeled estimates for each month at each 
location. The PM10 model and post­1999 and 
pre­1999 PM2.5 models were validated using 
cross­validation. This procedure involved divid­
ing the monitoring locations into 10 sets, and 
fitting the model with each set held out. Then, 
we calculated the squared correlation between 
held­out observations and predictions from 
the model with each set removed. We used 
sets 1‒9 to assess model performance, whereas 
we reserved set 10 to evaluate model over­
fitting. Each of these models performed well 
using cross­validation, exhibiting little bias and 
high precision (Paciorek et al. 2009; Yanosky 
et al. 2008, 2009). In comparison, predicted 
PM10‒2.5 levels exhibited little bias but were 
less precise (cross­validation results are detailed 
elsewhere) (Yanosky et al. 2009).
Evaluation of confounders and effect modi-
fiers. Data from the biennial questionnaires 
were used to assess potential confounding and 
effect modification by covariates, including 
hypertension (yes, no); physician­diagnosed dia­
betes (yes, no); hypercholesterolemia (yes, no); 
physical activity (< 3, 3 to < 9, 9 to < 18, 18 
to < 27, or ≥ 27 metabolic equivalent (MET) 
hr per week); body mass index (BMI) (con­
tinuous); smoking status (never, former, or cur­
rent); and smoking pack­years. Family history 
of MI (yes, no) was included based on answers 
to the 1976 and 1984 questionnaires. Census 
2000 data were used to assign two group­level 
socioeconomic status variables, median house­
hold income and median household value at 
the census tract level. Confounding was assessed 
through adjustment for each of these covari­
ates in individual and multivariate Cox models. 
Effect modification was evaluated through strat­
ification and the use of interaction terms.
Statistical analysis. Time­varying Cox pro­
portional hazards models were used to assess 
the relationship of all­cause mortality and 
CHD outcomes with PM2.5 and PM10‒2.5. 
These models were based on a monthly time 
scale and were used to estimate HRs and 95% 
CIs. Person­months of follow­up time were cal­
culated from baseline (30 June 1992) until the 
end of follow­up (30 June 2002), censoring at 
death or loss to follow­up. Person­time spent 
living outside the selected region was excluded, 
as were nurses with cancers or outcomes of inter­
est (e.g., nonfatal MI) reported prior to baseline. 
Incidence rates were estimated as the number 
of new cases divided by person­months of fol­
low­up. We focused on the average exposure to 
PM2.5 and PM10‒2.5 in the 12 months prior to 
the outcome of interest because a previous study 
has shown that to be the most relevant exposure 
(Schwartz et al. 2008). However, in separate 
models, we also considered other time windows 
of exposure, including average exposure in the 1, 
3, 24, 36, and 48 months prior to the event. We 
assessed PM2.5 and PM10‒2.5 in single­ and two­
pollutant models. All Cox models were strati­
fied by age in months and adjusted for state of 
residence (indicator variables), year (linear term), 
and season (indicator variables). By including 
state variables, the model adjusts for large­scale 
spatial patterns in mortality that might be caused 
by factors other than pollution, thereby esti­
mating the effect of pollution based on within­
state variation (Dominici et al. 2006; Pope et al. 
2002). All statistical analyses used SAS version 
9.1 (SAS Institute Inc., Cary, NC, USA). 
Results
The study population consisted of 66,250 
women who lived in MSAs in the north­
eastern and midwestern United States in 1992 
(Table 1) (Puett et al. 2008). Their mean age 
was 62.4 years. During the follow­up period, 
most were never or former smokers and 42% 
had a BMI under 25. Mean (± SD) levels of 
PM2.5 and PM10‒2.5 exposures in the previ­
ous 12 months were 13.9 ± 2.4 and 7.7 ± 2.6 
µg/m3, respectively (further details on PM 
described elsewhere) (Paciorek et al. 2009; 
Yanosky et al. 2009). There were 3,785 deaths; 
1,348 incident CHD events; 379 fatal CHDs; 
and 854 nonfatal MIs.
HRs and 95% CIs for all­cause mortality 
and other outcomes of interest for a 10­µg/m3 
unit change in PM2.5 and PM10‒2.5 averaged 
over the previous 12 months are presented in 
Table 2. In models adjusted for age, calen­
dar time, and state of residence, PM2.5 was 
significantly associated with all­cause mortal­
ity (HR = 1.45; 95% CI, 1.19‒1.78). Results 
also suggest PM10‒2.5 may be associated with 
increased mortality risk (HR = 1.13; 95% CI, 
0.98‒1.30). The HRs for both size fractions 
Table 1. Characteristics of the study population 
in selected categories from the Nurses’ Health 
Study during the follow­up period 1992–2002.a
Characteristic Statistic
No. 66,250
Age [years (mean ± SD)]  62.4 ± 7.6
BMI (%)
< 25.0 42.3
25.0 to < 30.0 34.2
> 30.0 23.5
Smoking status (%)
Never 43.6
Current 13.5
Former 42.9
Pack-years (mean ± SD) 24.8 ± 21.0
Hypercholesterolemia (%) 49.5
Diabetes (%) 7.4
Hypertension (%) 40.4
Family history of MI (%) 34.2
Physical activity (%)
< 3 MET hr/week 22.1
3 to < 9 MET hr/week 23.8
9 to < 18 MET hr/week 21.0
18 to < 27 MET hr/week 12.8
≥ 27 MET hr/week 20.3
Predicted PM2.5 µg/m3
Mean ± SD 13.9 ± 2.4
Minimum–maximum 5.8–27.6
IQR 12.0–15.6
Predicted PM10–2.5 µg/m3
Mean ± SD 7.7 ± 2.6
Minimum – maximum < 0.01–26.9
IQR 5.9–9.2
Median family income  
  in thousands (mean ± SD)b 
67.0 ± 24.1
Median house value  
  in ten thousands (mean ± SD)b 
16.6 ± 10.4
aPercentages based on complete information for partici­
pants. bEstimated for census tract of residence using 
data from the U.S. Census Bureau (2000). cData from 
Puett et al. (2008).PM2.5 and PM10–2.5 exposures, mortality, and CHD
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of PM and incident CHD were also elevated. 
Risks associated with fatal CHD were larger for 
PM2.5 (HR = 2.29; 95% CI, 1.26‒4.18) than 
for PM10‒2.5 (HR = 1.28; 95% CI, 0.82‒1.98) 
in crude models adjusted for age, calendar time, 
and state of residence. In sensitivity analyses 
using average annual PM2.5 exposure estimates 
from the nearest U.S. EPA AQS monitor in 
2000, as opposed to PM2.5 estimates from 
the time­varying geospatial model, the risks 
of all­cause mortality (HR = 1.35; 95% CI, 
1.08‒1.69) and fatal CHD (HR = 1.47; 95% 
CI, 0.73‒2.99) were attenuated but elevated. 
Fully adjusted models included hyperten­
sion, family history of MI, hypercholesterolemia, 
BMI, physical activity, smoking, diabetes, 
median house value, and household income for 
census tract of residence, season, and state of 
residence and were stratified by age in months 
(Table 2). Confounders were not highly cor­
related. The HRs were attenuated compared to 
models with limited control for confounding. 
PM2.5 was associated with all­cause mortality 
(HR =  1.26; 95% CI, 1.02‒1.54) and fatal 
CHD (HR =  2.02; 95% CI, 1.07‒3.78). Effect 
estimates for PM2.5 and PM10‒2.5 were generally 
stable in two pollutant models, although esti­
mates with all­cause mortality and fatal CHD 
were strengthened for PM2.5 and attenuated for 
PM10‒2.5. Overall, for nonfatal MI, the effect 
strengthened for PM10‒2.5. 
We assessed the sensitivity of our results 
to different time periods of exposure: 1, 3, 24, 
36, and 48 months before the event. In sin­
gle­pollutant, fully adjusted models of PM2.5 
exposure, the associations with each outcome 
(except nonfatal MI) were stronger with times 
greater than 3 months and similar among time 
periods 12‒48 months. In equivalent mod­
els for PM10‒2.5, there were no apparent dif­
ferences among exposure windows (data 
not shown). Results for different periods of 
exposure were similar for multipollutant fully 
adjusted models (Figure 1).
Table 3 shows relationships of PM2.5 
exposures in the previous 12 months with all­
cause mortality and fatal CHD adjusting for 
each potential confounder one at a time (after 
adjusting for state of residence, year, and sea­
son, and stratifying by age). For both fatal 
CHD and all­cause mortality, median house 
value for the census tract of residence elevated 
the risk, whereas physical activity attenuated 
the risk associated with PM2.5 exposures. 
Although no interaction terms were statis­
tically significant, stratified analyses for each 
covariate, adjusting for all other co  variates, 
showed some differences in the association 
between all­cause mortality and chronic PM2.5 
exposure (Table 4). Women with hyper­
cholesterolemia or in the lowest category of 
physical activity were at higher risk. Risks were 
greatest for nonsmokers and least for current 
smokers. There was no evidence of effect modi­
fication for the relationship between all­cause 
mortality and PM10‒2.5 (data not shown).
Women with a family history of MI 
were at significantly higher risk of fatal CHD 
associated with PM2.5 exposure (Table 4). 
Stratified analyses also suggested greater risks 
for women with hypertension, hypercholester­
olemia, larger BMIs, and living in census tracts 
in the lowest quartile of median house value 
or the lowest two quartiles of median family 
income. Never smokers showed the highest risk 
and current smokers, the least. Similar stratified 
differences by BMI and smoking were evident 
for PM10‒2.5 (data not shown). 
Discussion
In this study among women in the northeastern 
and midwestern region of the United States, we 
found each 10­µg/m3 elevation of PM2.5 expo­
sure in the previous 12 months was associated 
Table 2. HRs (95% CIs) for outcomes associated with a 10­µg/m3 change in average predicted PM2.5 and PM10–2.5 exposure in the previous 12 months.a
Fully adjusted modelsb
Crude modelsc Single-pollutant models Multipollutant modelsd
Cases Person-months PM2.5 PM10–2.5 PM2.5 PM10–2.5 PM2.5 PM10–2.5
All-cause mortality 3,785 606,752 1.45 (1.19–1.78) 1.13 (0.98–1.30) 1.26 (1.02–1.54) 1.03 (0.89–1.18) 1.29 (1.03–1.62) 0.96 (0.82–1.12)
First CHD 1,348 597,456 1.19 (0.85–1.65) 1.12 (0.89–1.42) 1.11 (0.79–1.55) 1.04 (0.82–1.32) 1.10 (0.76–1.60) 1.01 (0.78–1.31)
Fatal CHDe 379 597,456 2.29 (1.26–4.18) 1.28 (0.82–1.98) 2.02 (1.07–3.78) 1.14 (0.73–1.77) 2.13 (1.07–4.26) 0.91 (0.56–1.48)
Nonfatal MI 854 597,458 0.76 (0.50–1.15) 1.01 (0.75–1.36) 0.73 (0.48–1.12) 0.96 (0.71–1.30) 0.71 (0.44–1.13) 1.06 (0.77–1.47)
aThe moving average calculated for the 12 months previous to each risk set. bModels include age, state of residence, year, season, smoking status, family history of MI, BMI, hyper­
cholesterolemia, diabetes, hypertension, median family income in census tract of residence, physical activity, and median house value in census tract of residence. cModels stratified 
by age and adjusted for state of residence, year, and season. dPM2.5 and PM10–2.5 modeled simultaneously. eExcluding prior nonfatal MI.
Figure 1. HRs and 95% CIs for the association between all­cause and cause­specific mortality and a 10­µg/m3 
change in average PM2.5 and PM10–2.5 for six time periods of exposure.
aFine and coarse PM levels modeled simultaneously, stratified by age in months, adjusted for state of residence, year and 
season, smoking status, family history of MI, BMI, hypercholesterolemia, diabetes, hypertension, median family income in 
census tract of residence, physical activity, and median house value in census tract of residence.
4
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All cause First CHD Fatal CHD
Fine particulates Coarse particulates
Nonfatal MI All cause First CHD Fatal CHD Nonfatal MI
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3 months prior
12 months prior 
24 months prior
36 months prior
48 months prior
Table 3. Adjusted HRs (95% CIs) for all­cause and CHD mortality associated with a 10­µg/m3 change in 
average PM2.5 in prior 12 months.
Model covariates
All-cause  
mortality Fatal CHD First CHD Nonfatal MI
Time, residential state, season 1.45 (1.19–1.78) 2.29 (1.26–4.18) 1.19 (0.85–1.65) 0.76 (0.50–1.15)
Family history of MI 1.47 (1.20–1.79) 2.36 (1.29–4.31) 1.22 (0.87–1.69) 0.77 (0.51–1.18)
Hypercholesterolemia 1.46 (1.20–1.78) 2.34 (1.28–4.27) 1.21 (0.87–1.68) 0.77 (0.51–1.17)
Hypertension 1.44 (1.18–1.76) 2.29 (1.25–4.18) 1.18 (0.85–1.63) 0.75 (0.49–1.14)
BMI 1.44 (1.18–1.75) 2.25 (1.23–4.09) 1.21 (0.87–1.68) 0.79 (0.52–1.20)
Diabetes 1.44 (1.18–1.76) 2.26 (1.24–4.14) 1.17 (0.84–1.63) 0.75 (0.49–1.14)
Median household income 1.46 (1.20–1.78) 2.30 (1.26–4.17) 1.20 (0.87–1.67) 0.78 (0.51–1.17)
Median house value 1.56 (1.27–1.92) 2.60 (1.39–4.84) 1.28 (0.92–1.79) 0.81 (0.53–1.23)
Smoking 1.36 (1.11–1.66) 2.20 (1.20–4.02) 1.15 (0.83–1.61) 0.74 (0.49–1.13)
Physical activity 1.27 (1.04–1.55) 2.02 (1.11–3.70) 1.14 (0.82–1.59) 0.76 (0.50–1.16)
Full modela excluding  
  physical activity
1.36 (1.11–1.66) 2.15 (1.15–4.02) 1.14 (0.81–1.59) 0.74 (0.48–1.13)
Full modela 1.26 (1.02–1.54) 2.02 (1.07–3.78) 1.11 (0.79–1.55) 0.73 (0.48–1.12)
aAll models adjusted for state of residence, year, and season and stratified by age (months); full model includes all listed 
covariates. Puett et al.
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with an increased risk of all­cause mortality 
(HR = 1.26; 95% CI, 1.02‒1.54) and fatal 
CHD (HR = 2.02; 95% CI, 1.07‒3.78) after 
controlling for known risk factors. Although we 
found evidence of a positive association between 
PM10‒2.5 exposure and all­cause mortality, there 
was no association after adjustment for covari­
ates. An association between fatal CHD and 
PM10‒2.5 exposures was also evident but weaker 
in fully adjusted models. Finally, there was little 
evidence of an association between incident MI 
and PM. The relationship between PM2.5 and 
fatal CHD was modified by family history of 
MI, and nonsmokers were at greatest risk, sug­
gesting the strong impact of smoking exposures 
conceals the effects of air pollution. However, 
CIs were wide. The attenuation of risk of 
all­cause mortality and fatal CHD by physi­
cal activity as well as the increased risk of all­
cause mortality for women recording the least 
activity raises questions about the biological 
mechanism underlying these relationships. Few 
previous studies have examined the   influence of 
  physical activity.
These results are consistent with those 
observed in the growing body of literature on 
chronic air pollution and health effects. In the 
extended follow­up of the American Cancer 
Society (ACS) Study, a 10­µg/m3 change in 
PM2.5 was associated with an HR of 1.06 (95% 
CI, 1.02‒1.11) for all­cause mortality (Pope 
et al. 2002). The equivalent HR for a 10­µg/m3 
change in the updated Harvard Six Cities Study 
was 1.14 (95% CI, 1.06‒1.22) (Laden et al. 
2006). Recently, Eftim et al. (2008) replicated 
these analyses among Medicare patients resid­
ing in the same counties included in these two 
studies. Their results were more consistent with 
those observed in our cohort (ACS: HR for a 
10­µg/m3 change = 1.11; 95% CI, 1.09‒1.13; 
Six Cities: HR = 1.21; 95% CI, 1.15‒1.27). 
Specific associations with CHD also have been 
consistently observed. The Harvard Six Cities 
(Laden et al. 2006) and ACS (Pope et al. 2002) 
studies observed associations of 1.28 (95% CI, 
1.13‒1.44) for cardiovascular mortality and 
1.09 (95% CI, 1.03‒1.16) for cardiopulmo­
nary mortality, respectively. The recent WHI 
study reported overall risks of 2.21 (95% CI, 
1.17‒4.16) for cardiovascular mortality and 
1.76 (95% CI, 1.25‒2.47) for incident CHD 
(Miller et al. 2007). Two additional studies of 
men and women have found greater suscepti­
bility among women for cardiovascular events 
associated with particulate matter exposures 
(Chen et al. 2005; Rosenlund et al. 2006). 
Neither the original ACS study (Pope 
et al. 1995) nor the WHI study (Miller et al. 
2007) observed an association between all­cause 
mortality and chronic exposure to PM10‒2.5. 
However, the Harvard Six Cities study found 
an elevated relative risk associated with exposure 
to PM15‒2.5 (HR = 1.19; 95% CI, 0.91‒1.55) 
(U.S. EPA 1996). McDonnell et al. (2000) 
observed an HR of 1.05 (95% CI, 0.92‒1.20) 
for an IQR increase (9.7 µg/m3) in PM10‒2.5 
among men living near an airport in a cohort 
of Seventh­day Adventists. In an acute exposure 
study of fine and coarse particles in Shanghai, 
China, Kan et al. (2007) found no significant 
effect of PM10‒2.5 on mortality, but increases 
of total and cardiovascular mortality were 
reported. Other studies of acute exposure to 
coarse particulate matter have also suggested 
a relationship with cardiovascular outcomes 
(Host et al. 2008; Lipsett et al. 2006; Peng et al. 
2008; Tolbert et al. 2000), although Peng et al. 
(2008) reported the association between daily 
CVD hospital admissions and coarse particu­
late matter was no longer statistically significant 
when adjusted for PM2.5. We found a stronger 
association between coarse particulate matter and 
fatal CHD than with all­cause mortality in fully 
adjusted single­pollutant models and with nonfa­
tal MI in multipollutant models. In multipollut­
ant models, the WHI also found an association 
of PM2.5 (HR = 1.53; 95% CI, 1.21‒1.94) and 
PM10‒2.5 (HR = 1.10; 95% CI, 0.97‒1.23) with 
first cardiovascular event (Miller et al. 2007).
In general, our results are elevated in rela­
tion to other studies, with the exception of 
the WHI, another cohort study of women. 
This disparity could be due in part to the use 
of different air pollution exposure estimation 
methods. We modeled monthly exposures for 
each biennially updated residential address 
using GIS­based spatial smoothing models. 
For example, the ACS study used mean expo­
sure in metropolitan areas measured during 
a few of the years of follow­up (Pope et al. 
1995). A reanalysis restricting to subjects with 
monitors in their county of residence reported 
higher risks (Willis et al. 2003). Additionally, 
a study in Southern California using spatially 
estimated exposures reported stronger results 
(Jerrett et al. 2005). To the extent that our 
exposure modeling accounts for local variation 
that other studies do not, we might be cap­
turing different sources of pollution resulting 
in different effect sizes. Further, our sensitiv­
ity analyses, using a less­precise exposure esti­
mate, showed an attenuation of the effect size. 
Therefore, it appears that studies using spa­
tially estimated exposure measures may pro­
duce higher risk estimates. This has important 
implications for risk assessment.
Table 4. All­cause and CHD mortality and first CHD associated with 10­µg/m3 change in average PM2.5 in 
prior 12 months, stratified by potential effect modifiers.
Modifier
All-cause mortality Fatal CHD First CHD
Cases HR (95% CI) Cases HR (95% CI) Cases HR (95% CI)
Diabetes
  No 2,970 1.27 (1.01–1.61) 240 1.85 (0.83–4.11) 1,001 1.00 (0.68–1.49)
  Yes 815 1.19 (0.77–1.85) 139 1.90 (0.67–5.43) 347 1.22 (0.63–2.37)
Family history of MI
  No 2,352 1.02 (0.79–1.32) 217 1.31 (0.57–3.00) 746 0.96 (0.61–1.51)
  Yes 1,433 1.85 (1.32–2.60) 162 3.50 (1.33–9.24)* 602 1.28 (0.77–2.13)
Hypercholesterolemia
  No 1,798 1.04 (0.77–1.40) 154 1.46 (0.53–4.04) 494 1.23 (0.70–2.15)
  Yes 1,987 1.53 (1.15–2.03) 225 2.38 (1.07–5.32) 854 1.03 (0.67–1.57)
Hypertension
  No 1,505 1.40 (1.01–1.94) 108 1.21 (0.37–4.01) 437 1.20 (0.66–2.17)
  Yes 2,280 1.17 (0.90–1.53) 271 2.27 (1.07–4.79) 911 1.02 (0.68–1.54)
Smoking
  Never 1,091 1.45 (1.00–2.11) 126 4.55 (1.52–13.58) 445 1.18 (0.66–2.11)
  Former 1,785 1.29 (0.95–1.75) 142 2.36 (0.83–6.73) 566 1.21 (0.71–2.05)
  Current 791 1.04 (0.66–1.63) 98 0.71 (0.20–2.50) 314 1.04 (0.52–2.10)
Physical activity (MET hr)
  0–3 1,007 1.56 (1.04–2.34) 95 3.69 (1.03–13.23) 311 1.69 (0.83–3.44)
3–18 899 1.05 (0.69–1.60) 81 1.01 (0.25–4.01) 497 0.79 (0.45–1.40)
> 18 234 0.91 (0.40–2.09) 28 0.15 (0.01–1.58) 145 0.64 (0.23–1.79)
Median house value
  Quartile 1 866 1.16 (0.78–1.71) 98 3.63 (1.20–11.00) 345 0.94 (0.51–1.73)
  Quartile 2 963 1.25 (0.83–1.88) 91 2.34 (0.75–7.32) 359 1.14 (0.59–2.20)
  Quartile 3 1,007 1.07 (0.68–1.67) 102 1.41 (0.49–4.06) 353 1.04 (0.49–2.18)
  Quartile 4 942 1.24 (0.76–2.02) 87 1.38 (0.41–4.66) 287 1.93 (0.81–4.59)
Median family income
  Quartile 1 888 1.04 (0.71–1.52) 97 2.33 (0.85–6.34) 335 0.68 (0.38–1.23)
  Quartile 2 984 1.49 (1.00–2.21) 97 6.19 (1.98–19.40) 377 2.46 (1.31–4.62)
  Quartile 3 1,023 1.03 (0.67–1.58) 102 0.61 (0.18–2.03) 354 0.72 (0.35–1.49)
  Quartile 4 890 1.09 (0.66–1.81) 83 1.44 (0.30–6.91) 282 1.44 (0.59–3.51)
BMI
  < 30 2,817 1.30 (1.02–1.65) 248 1.09 (0.06–19.98) 927 0.85 (0.56–1.29)
> 30 827 1.76 (1.15–2.70) 115 3.02 (0.97–9.40) 389 1.97 (1.06–3.63)
The model was stratified by age in months, adjusted for state of residence, year and season, smoking status, family 
history of MI, hypercholesterolemia, diabetes, hypertension, BMI, median family income in census tract of residence, 
physical activity, and median house value in census tract of residence. 
*Interaction significant at p < 0.05. PM2.5 and PM10–2.5 exposures, mortality, and CHD
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Because PM10‒2.5 estimates were derived 
from PM10 and PM2.5 estimates, more uncer­
tainty is associated. This may contribute to the 
lower effect estimates we observed for PM10‒2.5, 
but Yanosky et al. (2009) show that long­term 
average PM10‒2.5 was reasonably well estimated 
(cross­validation R2 = 0.63 and 0.65 for long­
term post­1999 and pre­1999 PM10‒2.5, respec­
tively). To improve our exposure modeling, we 
focused on the northeastern and midwestern 
United States (63% of the total study popula­
tion), an area with more uniformly distributed 
study population and monitors, and results 
may differ for other U.S. regions. In addition, 
we were unable to account for nurses who 
moved between the biennial questionnaires 
or for lengthy stays away from their residence 
in another geographic region. We estimated 
time­ and space­resolved exposures with GIS­
based smoothing models. Although smooth­
ing reduces variability relative to measured 
concentrations, Gryparis et al. (2008) show 
this is a type of Berkson measurement error 
that should not cause substantial bias toward 
the null. Additionally, modeling allows us to 
assign exposures specific to biennially updated 
residential addresses for the entire period of 
follow­up. Thus, compared with using only 
monitor measurements, fewer participants are 
lost because of missing exposure data. 
A strength of this study is that we have 
updated information on numerous covariates 
throughout the follow­up period. However, 
there does exist the possibility of residual 
confounding or confounding by unmeasured 
covariates and/or by additional pollutants.
Biological mechanisms for the relationship 
of particulate matter exposure with mortality 
and CVD have not yet been fully explained. 
Several mechanisms have been proposed, 
including changes in autonomic function, oxi­
dative stress, and systemic inflammation leading 
to endothelial dysfunction, thrombosis, or ath­
erosclerosis (Donaldson et al. 2001; Gurgueira 
et al. 2002; Pope et al. 2004; Pope and Dockery 
2006; Utell et al. 2002). Although fine par­
ticles deposit deeper into the lung (Brunekreef 
and Forsberg 2005; Venkataraman and Kao 
1999), some studies have shown coarse particles 
have a greater ability to stimulate inflammatory 
responses and macrophages cytokine produc­
tion (Becker et al. 2002, 2005; Brunekreef and 
Forsberg 2005).
Conclusions
Our findings contribute to growing evidence 
that annual exposure to particles is associated 
with increases in risk of all­cause and cardiovas­
cular mortality. The extended follow­up of the 
Harvard Six Cities study (Laden et al. 2006) 
found mortality risks associated with exposure 
in the year of death were similar to those for 
the entire follow­up period. In another reanaly­
sis, Schwartz et al. (2008) reported that the 
association was with exposure in the previous 
2 years. A recent study of a Medicare cohort of 
MI survivors and PM10 exposure examined the 
effect of multiple lags of exposure on survival. 
Again, the effect of particles on mortality risk 
seemed to go back only a few years (Zanobetti 
and Schwartz 2007).
In summary, with chronic coarse and fine 
particulate exposures estimated on a finer spa­
tial and temporal scale than in previous cohort 
studies (Dockery et al. 1993; Pope et al. 1995), 
we found PM2.5 was associated with increased 
risks of all­cause mortality and fatal CHD. 
Coarse particulate matter exposures were not 
associated with an increase in risk after control 
for confounders. In addition, our results sug­
gest that health benefits may be evident within 
a few years of reductions in particle levels.
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